Literature DB >> 19140088

Cotrimoxazole resistance of Streptococcus pneumoniae and commensal streptococci from Kampala, Uganda.

Maria Wilén1, William Buwembo, Hakim Sendagire, Fred Kironde, Göte Swedberg.   

Abstract

Trimethoprim sulfamethoxazole (cotrimoxazole, CTX) is used frequently as part of standard medical care for people living with HIV/AIDS in Africa. The mechanisms of resistance to sulfonamides and trimethoprim in commensal streptococci from Uganda were determined and compared to S. pneumoniae. Commensal streptococci showing high-level resistance to cotrimoxazole were cultured and analysed for species identity and polymorphisms in the genes coding for dihydropteroate synthase (DHPS) and dihydrofolate reductase (DHFR). Seven isolates of S. pneumoniae from blood and cerebrospinal fluid (CSF) were similarly examined. There was considerable polymorphism in both DHPS and DHFR. In DHFR, the mutations E20D and I100L were present in all sequenced isolates. Other mutations such as L135F, and different substitutions in D92, were frequent. The most common DHPS variants had 2 serine residues added after amino acid 60, or arginine and proline added after amino acid 59. In addition, 3 new insertions/substitutions were found. There were no obvious differences between the mutation patterns in S. pneumoniae and commensal streptococci, suggesting that the chromosomal mutations have been spread by transformational interchanges of DNA among related organisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19140088     DOI: 10.1080/00365540802651889

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  10 in total

1.  Malaria Parasitemia and Parasite Density in Antiretroviral-Treated HIV-Infected Adults Following Discontinuation of Cotrimoxazole Prophylaxis.

Authors:  Ronald K Ottichilo; Christina S Polyak; Bernard Guyah; Benson Singa; Josphat Nyataya; Krista Yuhas; Grace John-Stewart; John N Waitumbi
Journal:  J Infect Dis       Date:  2016-10-25       Impact factor: 5.226

2.  Gain- and Loss-of-Function Screens Coupled to Next-Generation Sequencing for Antibiotic Mode of Action and Resistance Studies in Streptococcus pneumoniae.

Authors:  Hélène Gingras; Kévin Patron; Arijit Bhattacharya; Philippe Leprohon; Marc Ouellette
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

3.  Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled trial.

Authors:  Shahin Lockman; Michael Hughes; Kate Powis; Gbolahan Ajibola; Kara Bennett; Sikhulile Moyo; Erik van Widenfelt; Jean Leidner; Kenneth McIntosh; Loeto Mazhani; Joseph Makhema; Max Essex; Roger Shapiro
Journal:  Lancet Glob Health       Date:  2017-05       Impact factor: 26.763

4.  Prolonged Cotrimoxazole Prophylaxis Has No Impact on Child Growth in the First Two Years of Life: Findings from a Randomized Controlled Trial in Botswana.

Authors:  Aamirah Mussa; Kathleen M Powis; Shahin Lockman; Gbolahan Ajibola; Chelsea Morroni; Laura Smeaton; Mompati Mmalane; Joseph Makhema; Roger L Shapiro
Journal:  J Pediatr       Date:  2022-03-26       Impact factor: 6.314

5.  Cotrimoxazole Prophylaxis Specifically Selects for Cotrimoxazole Resistance in Streptococcus mutans and Streptococcus sobrinus with Varied Polymorphisms in the Target Genes folA and folP.

Authors:  Buwembo William; Charles Mugisha Rwenyonyi; Göte Swedberg; Fred Kironde
Journal:  Int J Microbiol       Date:  2012-01-24

6.  The "child size medicines" concept: policy provisions in Uganda.

Authors:  Jasper Ogwal-Okeng; Anthony Mbonye; Freddie Ssengooba; Rebecca Nantanda; Herbert Muyinda; Ebba Holme Hansen; Xavier Nsabagasani
Journal:  J Pharm Policy Pract       Date:  2015-01-31

7.  Availability and utilization of the WHO recommended priority lifesaving medicines for under five-year old children in public health facilities in Uganda: a cross-sectional survey.

Authors:  Xavier Nsabagasani; Jasper Ogwal-Okeng; Anthony Mbonye; Freddie Ssengooba; Simon Muhumuza; Ebba Holme Hansen
Journal:  J Pharm Policy Pract       Date:  2015-05-11

8.  Point Mutations in the folP Gene Partly Explain Sulfonamide Resistance of Streptococcus mutans.

Authors:  W Buwembo; S Aery; C M Rwenyonyi; G Swedberg; F Kironde
Journal:  Int J Microbiol       Date:  2013-02-25

9.  Genomic identification of a novel co-trimoxazole resistance genotype and its prevalence amongst Streptococcus pneumoniae in Malawi.

Authors:  Jennifer E Cornick; Simon R Harris; Christopher M Parry; Michael J Moore; Chikondi Jassi; Arox Kamng'ona; Benard Kulohoma; Robert S Heyderman; Stephen D Bentley; Dean B Everett
Journal:  J Antimicrob Chemother       Date:  2013-09-29       Impact factor: 5.790

10.  Recombinant expression, purification and PEGylation of Paneth cell peptide (cryptdin-2) with value added attributes against Staphylococcus aureus.

Authors:  Navneet Kaur; Rahul Dilawari; Amrita Kaur; Girish Sahni; Praveen Rishi
Journal:  Sci Rep       Date:  2020-07-22       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.